Advertisement

Topics

Horizon submits BLA to FDA for thyroid eye disease drug teprotumumab

05:06 EDT 12 Jul 2019 | SmartBrief

Horizon Therapeutics has filed a US marketing application for its experimental drug teprotumumab as a treatment for active th -More

Original Article: Horizon submits BLA to FDA for thyroid eye disease drug teprotumumab

NEXT ARTICLE

More From BioPortfolio on "Horizon submits BLA to FDA for thyroid eye disease drug teprotumumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...